Smart Pectin-based Superabsorbent Hydrogel as a Matrix for Ibuprofen as an Oral Non-steroidal Anti-inflammatory Drug Delivery

The purpose of this study was to produce an intelligent superabsorbent polymer (SAP) to be used as a pH sensitive matrix for the controlled delivery of drugs. Novel types of highly swelling SAPs were prepared by grafting crosslinked acrylic acid-co-acrylamide (AA-co-AAm) chains onto pectin by free-r...

Full description

Saved in:
Bibliographic Details
Published inDie Stärke Vol. 61; no. 3-4; pp. 173 - 187
Main Authors Pourjavadi, Ali, Barzegar, Shahram
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.04.2009
WILEY-VCH Verlag
WILEY‐VCH Verlag
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to produce an intelligent superabsorbent polymer (SAP) to be used as a pH sensitive matrix for the controlled delivery of drugs. Novel types of highly swelling SAPs were prepared by grafting crosslinked acrylic acid-co-acrylamide (AA-co-AAm) chains onto pectin by free-radical polymerization. The superabsorbent formation was confirmed by Fourier transform infrared spectroscopic (FT-IR) and scanning electron microscopy (SEM). The controlled release behavior of ibuprofen (IBU) from the superabsorbent polymer was investigated. SAP structural-property relationships that affect its controlled release behavior were determined. Analysis of the results indicated that it is possible to optimize ibuprofen (IBU) controlled release by adjusting the SAP composition and the crosslinking degree of the copolymer. The results revealed that the release profiles of IBU from the superabsorbent polymer were slow (lower than 2%) in simulated gastric fluid (SGF, pH 1.2) over 3 h, but nearly all of the initial drug content (more than 84%) was released in simulated intestinal fluid (SIF, pH 7.4) within 85 h after changing media. Overall the results demonstrated that biodegradable superabsorbents could successfully deliver a drug to the intestine without losing the drug in the stomach, and could be potential candidates as an orally administrated drug delivery system.
Bibliography:http://dx.doi.org/10.1002/star.200800032
istex:F04ECFB8DEE245E0BC979BB652B62C8D61CD376B
ark:/67375/WNG-6LNSN1CV-R
ArticleID:STAR200800032
ISSN:0038-9056
1521-379X
DOI:10.1002/star.200800032